Response to "Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?"

CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):511-512. doi: 10.1002/psp4.13135. Epub 2024 Mar 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cystic Fibrosis* / drug therapy
  • Humans